PL1648473T3 - Pojedyncza dawka szybko rozpuszczającej się azytromycyny - Google Patents
Pojedyncza dawka szybko rozpuszczającej się azytromycynyInfo
- Publication number
- PL1648473T3 PL1648473T3 PL04744019T PL04744019T PL1648473T3 PL 1648473 T3 PL1648473 T3 PL 1648473T3 PL 04744019 T PL04744019 T PL 04744019T PL 04744019 T PL04744019 T PL 04744019T PL 1648473 T3 PL1648473 T3 PL 1648473T3
- Authority
- PL
- Poland
- Prior art keywords
- single dose
- fast dissolving
- azithromycin
- dissolving azithromycin
- dose fast
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 3
- 229960004099 azithromycin Drugs 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49018703P | 2003-07-24 | 2003-07-24 | |
| PCT/IB2004/002359 WO2005009447A1 (en) | 2003-07-24 | 2004-07-22 | Single dose fast dissolving azithromycin |
| EP04744019A EP1648473B1 (en) | 2003-07-24 | 2004-07-22 | Single dose fast dissolving azithromycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1648473T3 true PL1648473T3 (pl) | 2009-07-31 |
Family
ID=34102966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04744019T PL1648473T3 (pl) | 2003-07-24 | 2004-07-22 | Pojedyncza dawka szybko rozpuszczającej się azytromycyny |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7572773B2 (pl) |
| EP (1) | EP1648473B1 (pl) |
| AT (1) | ATE421882T1 (pl) |
| DE (1) | DE602004019288D1 (pl) |
| PL (1) | PL1648473T3 (pl) |
| WO (1) | WO2005009447A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| CA2549225A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride |
| ATE399536T1 (de) * | 2003-12-04 | 2008-07-15 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| BRPI0416534A (pt) | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
| EP1694304A2 (en) * | 2003-12-04 | 2006-08-30 | Pfizer Products Inc. | Azithromycin multiparticulate dosage forms by liquid-based processes |
| US9198862B2 (en) | 2005-07-22 | 2015-12-01 | Rubicon Research Private Limited | Dispersible tablet composition |
| US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| RU2512683C2 (ru) | 2012-06-08 | 2014-04-10 | Общество с ограниченной ответственностью "ВИК-здоровье животных" | Антибактериальная инъекционная фармацевтическая композиция |
| CN104825408A (zh) * | 2012-12-31 | 2015-08-12 | 四川科伦药业股份有限公司 | 一种阿奇霉素分散片及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| HRP940251B1 (en) | 1994-04-15 | 1998-12-31 | Stjepan Mutak | Process for the preparation of azithromycin dihydrochloride |
| US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
| US6245903B1 (en) | 1998-08-21 | 2001-06-12 | Apotex, Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| ES2267549T3 (es) * | 1999-06-29 | 2007-03-16 | Sandoz Ag | Procedimiento para la produccion de azitromicina. |
| KR100491183B1 (ko) | 2001-03-21 | 2005-05-25 | 한미약품 주식회사 | 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물 |
| KR100431431B1 (ko) * | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| DK1390377T3 (da) | 2001-05-22 | 2006-06-19 | Pfizer Prod Inc | Ny krystalform af azithromycin |
| US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| EP1418924A2 (en) * | 2001-08-21 | 2004-05-19 | Pfizer Products Inc. | Single dose azithromycin for treating respiratory infections |
| US6855813B2 (en) | 2002-07-19 | 2005-02-15 | Alembic Limited | Process for the preparation of azithromycin monohydrate |
-
2004
- 2004-07-22 EP EP04744019A patent/EP1648473B1/en not_active Expired - Lifetime
- 2004-07-22 DE DE602004019288T patent/DE602004019288D1/de not_active Expired - Fee Related
- 2004-07-22 US US10/898,147 patent/US7572773B2/en not_active Expired - Fee Related
- 2004-07-22 AT AT04744019T patent/ATE421882T1/de not_active IP Right Cessation
- 2004-07-22 PL PL04744019T patent/PL1648473T3/pl unknown
- 2004-07-22 WO PCT/IB2004/002359 patent/WO2005009447A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005009447A1 (en) | 2005-02-03 |
| ATE421882T1 (de) | 2009-02-15 |
| EP1648473A1 (en) | 2006-04-26 |
| US7572773B2 (en) | 2009-08-11 |
| US20050026851A1 (en) | 2005-02-03 |
| DE602004019288D1 (de) | 2009-03-19 |
| EP1648473B1 (en) | 2009-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
| TNSN04065A1 (en) | Treatment of acute myeloid leukemia with indolinone compounds | |
| MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
| TWI327573B (en) | 6-11 bicyclic ketolide derivatives | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
| MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
| PL365285A1 (pl) | Kompozycje farmaceutyczne do leczenia raka | |
| JO2282B1 (en) | Oxazole derivatives | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| GB0413087D0 (en) | Therapeutic compounds | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| AP1729A (en) | Single dose azithromycin for treating respiratory infections. | |
| PL1648473T3 (pl) | Pojedyncza dawka szybko rozpuszczającej się azytromycyny | |
| MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
| PL360492A1 (pl) | Zastosowanie kwasu pamowego lub jednej z jego pochodnych lub jednego z jego analogów do wytwarzanialeku do leczenia chorób charakteryzujących się odkładaniem amyloidowych agregatów | |
| TW200634021A (en) | 3,6-bicyclolides | |
| NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| MXPA03006359A (es) | Metodo para tratamiento del cancer. | |
| IL151878A0 (en) | Pharmaceutical compositions containing t3 | |
| WO2005025556A3 (en) | Antibiotic cycloalkyltetrahydroquinoline derivatives | |
| UA3175U (uk) | Спосіб лікування розсіяного склерозу | |
| MY139960A (en) | Treatment of acute myeloid leukemia with indolinone compounds |